BPTH OTC
Bio-Path Holdings, Inc.
1W: -40.0%
1M: -98.5%
3M: -99.3%
YTD: -99.5%
1Y: -99.6%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±197.0%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$159K
+10.7% ▲
Operating Income
-$12M
+24.3% ▲
Net Income
-$10M
+38.5% ▲
EPS (Diluted)
$-4.12
+87.8% ▲
EBITDA
-$10M
+38.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $151K | $161K | $178K | $178K | $159K |
| Gross Profit | -$151K | -$161K | -$178K | -$178K | -$159K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $7M | $6M | $9M | $12M | $7M |
| SG&A Expenses | $4M | $5M | $5M | $4M | $5M |
| Operating Expenses | $11M | $10M | $14M | $16M | $12M |
| Operating Income | -$11M | -$10M | -$14M | -$16M | -$12M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$11M | -$10M | -$14M | -$16M | -$10M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$11M | -$10M | -$14M | -$16M | -$10M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-56.44 | $-31.04 | $-38.03 | $-33.64 | $-4.12 |
| EBITDA | -$11M | -$10M | -$14M | -$16M | -$10M |
| Shares Outstanding | 192350 | 336250 | 363800 | 478000 | 2M |